139 related articles for article (PubMed ID: 30952752)
21. Expression and prognostic value of c-met in canine mammary tumours.
Chen YC; Chen YY; Liao JW; Chang SC
Vet Comp Oncol; 2018 Dec; 16(4):670-676. PubMed ID: 30129270
[TBL] [Abstract][Full Text] [Related]
22. The role of Cox-2 expression in the prognosis of dogs with malignant mammary tumours.
Queiroga FL; Pires I; Lobo L; Lopes CS
Res Vet Sci; 2010 Jun; 88(3):441-5. PubMed ID: 19939424
[TBL] [Abstract][Full Text] [Related]
23. Down-expression of klotho in canine mammary gland tumors and its prognostic significance.
Chung H; Lee S; Kim GA; Kim WH
PLoS One; 2022; 17(6):e0265248. PubMed ID: 35666743
[TBL] [Abstract][Full Text] [Related]
24. Postoperative treatment outcome in canine mammary tumors. Multivariate analysis of the prognostic value of pre- and postoperatively available information.
Betz D; Schoenrock D; Mischke R; Baumgärtner W; Nolte I
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(4):235-42. PubMed ID: 22911254
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of galectin-1 and galectin-3 in canine non-malignant and malignant mammary tissues and in progression to metastases in mammary tumors.
DE Oliveira JT; DE Matos AJ; Barros R; Ribeiro C; Chen A; Hespanhol V; Rutteman GR; Gärtner F
Anticancer Res; 2014 May; 34(5):2211-21. PubMed ID: 24778023
[TBL] [Abstract][Full Text] [Related]
26. Concurrent expression of cyclo-oxygenase-2 and epidermal growth factor receptor in canine malignant mammary tumours.
Guimarães MJ; Carvalho MI; Pires I; Prada J; Gil AG; Lopes C; Queiroga FL
J Comp Pathol; 2014 Jan; 150(1):27-34. PubMed ID: 24060154
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical study of IGF-I and IGF-II expression in canine mammary tumours: Prognostic and diagnostic role.
Ozmen O
Acta Vet Hung; 2020 Sep; 68(3):269-274. PubMed ID: 33221734
[TBL] [Abstract][Full Text] [Related]
28. Significance of caveolin-1 and matrix metalloproteinase 14 gene expression in canine mammary tumours.
Ebisawa M; Iwano H; Nishikawa M; Tochigi Y; Komatsu T; Endou Y; Hirayama K; Taniyama H; Kadosawa T; Yokota H
Vet J; 2015 Nov; 206(2):191-6. PubMed ID: 26364240
[TBL] [Abstract][Full Text] [Related]
29. The relationship between clinicopathological features and expression of epithelial and mesenchymal markers in spontaneous canine mammary gland tumors.
Yoshida K; Yoshida S; Choisunirachon N; Saito T; Matsumoto K; Saeki K; Mochizuki M; Nishimura R; Sasaki N; Nakagawa T
J Vet Med Sci; 2014 Oct; 76(10):1321-7. PubMed ID: 24931646
[TBL] [Abstract][Full Text] [Related]
30. MUC1 expression in canine malignant mammary tumours and relationship to clinicopathological features.
de Oliveira JT; Pinho SS; de Matos AJ; Hespanhol V; Reis CA; Gärtner F
Vet J; 2009 Dec; 182(3):491-3. PubMed ID: 18948041
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-8 expression associated with canine mammary tumors.
Zuccari DA; Castro R; Gelaleti GB; Mancini UM
Genet Mol Res; 2011; 10(3):1522-32. PubMed ID: 21863548
[TBL] [Abstract][Full Text] [Related]
32. A canine model of familial mammary gland neoplasia.
Schafer KA; Kelly G; Schrader R; Griffith WC; Muggenburg BA; Tierney LA; Lechner JF; Janovitz EB; Hahn FF
Vet Pathol; 1998 May; 35(3):168-77. PubMed ID: 9598580
[TBL] [Abstract][Full Text] [Related]
33. Relationship between NF-κB expression and malignancy of canine mammary gland tumor tissues.
Mkaouar L; Endo Y; Jun HX; Lee SJ; Jaroensong T; Mochizuki M; Uchida K; Nakayama H; Sasaki N; Nakagawa T
J Vet Med Sci; 2012 Jun; 74(6):713-8. PubMed ID: 22222165
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical staining of metallothionein in canine mammary tumors: better survival with higher expression.
Cardoso SV; Caliari MV; de Aguiar MC; Cassali GD
Oncol Rep; 2004 Dec; 12(6):1317-21. PubMed ID: 15547757
[TBL] [Abstract][Full Text] [Related]
35. Expression and prognostic significance of CK19 in canine malignant mammary tumours.
Gama A; Alves A; Schmitt F
Vet J; 2010 Apr; 184(1):45-51. PubMed ID: 19264518
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathological significance of caspase-3 and Ki-67 expression in canine mammary gland tumours.
Rodrigues H; Carvalho MI; Pires I; Prada J; Queiroga FL
Acta Vet Hung; 2016 Mar; 64(1):78-89. PubMed ID: 26919145
[TBL] [Abstract][Full Text] [Related]
37. Loss of p27 expression in canine mammary tumors and their metastases.
Klopfleisch R; Schütze M; Gruber AD
Res Vet Sci; 2010 Apr; 88(2):300-3. PubMed ID: 19748645
[TBL] [Abstract][Full Text] [Related]
38. Expression of glutathione, glutathione peroxidase and glutathione S-transferase pi in canine mammary tumors.
Leonel C; Gelaleti GB; Jardim BV; Moschetta MG; Regiani VR; Oliveira JG; Zuccari DA
BMC Vet Res; 2014 Feb; 10():49. PubMed ID: 24565113
[TBL] [Abstract][Full Text] [Related]
39. Vitamin D receptor expression in canine mammary gland and relationship with clinicopathological parameters and progesterone/oestrogen receptors.
Sánchez-Céspedes R; Fernández-Martínez MD; Raya A; Pineda C; López I; Millán Y
Vet Comp Oncol; 2018 Mar; 16(1):E185-E193. PubMed ID: 29178579
[TBL] [Abstract][Full Text] [Related]
40. The prognostic significance of angiogenesis in canine mammary tumors.
Graham JC; Myers RK
J Vet Intern Med; 1999; 13(5):416-8. PubMed ID: 10499723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
